Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 14.67 8.07 3.01 15.87 11.00
Fund with Sales Charge (%) (POP) 8.36 6.06 1.85 15.22 10.72
NASDAQ Biotechnology Index (%) 9.50 9.45 3.38 16.74 11.70
S&P 500 Index (%) 16.11 14.89 10.98 13.44 7.70
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.49 0.01 0.70 13.02 10.06
Fund with Sales Charge (%) (POP) -22.02 -1.85 -0.44 12.38 9.78
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

After-Tax Average Annual Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 13.39 7.02 1.65 14.64
Fund without Sales Charge (%) (NAV) After Shares Sold 8.79 5.93 1.92 13.07
Fund with Sales Charge (%) (POP) Before Shares Sold 7.14 5.01 0.50 14.00
Fund with Sales Charge (%) (POP) After Shares Sold 5.05 4.34 1.03 12.48
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.41 -0.97 -0.64 11.81
Fund without Sales Charge (%) (NAV) After Shares Sold -10.13 -0.17 0.29 10.64
Fund with Sales Charge (%) (POP) Before Shares Sold -22.90 -2.81 -1.75 11.18
Fund with Sales Charge (%) (POP) After Shares Sold -12.83 -1.57 -0.57 10.07

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28 11.83
Fund with Sales Charge (%) (POP) -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54 5.41
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 11/30/2019

Month EndAs of 11/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 15.86 30.44 14.67 26.23 16.01 336.41 915.58
Fund with Sales Charge (%) (POP) 9.49 23.27 8.36 19.29 9.62 312.38 859.54
NASDAQ Biotechnology Index (%) 16.09 23.37 9.50 31.09 18.10 370.05 1,067.34
S&P 500 Index (%) 7.86 27.63 16.11 51.62 68.34 252.89 419.20
Quarter EndAs of 09/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -14.27 6.21 -17.49 0.04 3.54 239.92 726.94
Fund with Sales Charge (%) (POP) -18.98 0.37 -22.02 -5.46 -2.16 221.19 681.31
NASDAQ Biotechnology Index (%) -8.76 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 1.70 20.55 4.25 45.80 67.27 246.74 390.39

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 11/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.57 24.83 22.77
Standard Deviation (NASDAQ Biotechnology Index) 20.74 23.21 21.08
Beta 1.05 1.04 1.04
Sharpe Ratio 0.29 0.08 0.67
Information Ratio -0.24 -0.07 -0.15
Tracking Error 5.89 5.71 5.97

ADDITIONAL RISK STATISTICSAs of 11/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.04 0.97 1.05
Beta Bear 0.93 1.01 1.02
Bull Bear Capture Ratio 0.98 1.03 0.98
Gains/Losses 1.39 1.20 1.75

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 11/30/2019 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.29
Standard Deviation 22.57

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index